The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay
- PMID: 30230346
- PMCID: PMC7212797
- DOI: 10.1164/rccm.201807-1396LE
The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay
Comment in
-
Reply to Fitzmaurice et al.: The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay.Am J Respir Crit Care Med. 2018 Dec 15;198(12):1587-1588. doi: 10.1164/rccm.201808-1477LE. Am J Respir Crit Care Med. 2018. PMID: 30230349 Free PMC article. No abstract available.
Comment on
-
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164. doi: 10.1164/rccm.201803-0590OC. Am J Respir Crit Care Med. 2018. PMID: 29787288 Clinical Trial.
References
-
- Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, et al. LIBERATE Study Group. A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE) Am J Respir Crit Care Med. 2018;198:1151–1164. - PubMed
-
- Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, et al. TRANSFORM Study Team. A multicentre randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM) Am J Respir Crit Care Med. 2017;196:1535–1543. - PubMed
-
- Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373:2325–2335. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
